Login to Your Account



Other News To Note


Wednesday, July 31, 2013
• Antitope Ltd., of Cambridge, UK, signed a research agreement with Faron Pharmaceuticals Ltd., of Turku, Finland, to generate therapeutic monoclonal antibodies against the Clever-1 receptor.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription